OCT West Coast 2026 brings together clinical trial professionals from pharmaceutical and biotechnology organizations to address the evolving operational, regulatory, and technological challenges of clinical development. The conference emphasizes collaboration, operational efficiency, innovation, and patient centricity across the clinical trial lifecycle.

The 2026 program features four dedicated content streams covering outsourcing and clinical operations, AI and technology transformation, patient centricity, and a new Biotech Strategy stream focused on drug development challenges and strategies from a small biotech perspective. Attendees will have the opportunity to exchange insights, explore targeted trial approaches, and connect with regional industry leaders.

BIO-Europe Spring is a premier partnering conference connecting senior executives from biotechnology, pharmaceutical, and life sciences companies with investors, service providers, and strategic partners from around the world. The event focuses on early-stage innovation and growth-oriented companies, with an emphasis on business development, licensing, and investment opportunities.

Featuring structured one-on-one partnering meetings, company presentations, and targeted networking, BIO-Europe Spring provides a platform to explore emerging science, deal-making trends, and collaboration opportunities across the global life sciences ecosystem.

RESI Europe is an investor-focused partnering conference connecting early-stage and emerging life sciences, healthcare, and medtech companies with global investors and strategic partners. The event emphasizes curated one-on-one meetings, company presentations, and networking opportunities designed to support capital formation and strategic growth.

RESI Europe brings together startups, venture capital firms, family offices, corporate venture groups, and industry leaders to explore innovation across biotechnology, medical devices, diagnostics, and digital health within the European life sciences ecosystem.

LSX World Congress Europe (LSX Europe) is a leading life sciences fundraising and investment event bringing together innovative early-stage companies with active global investors. The congress focuses on strategic one-on-one meetings and targeted networking designed to support capital raising and long-term partnerships.

Attendees include biotechnology, medical devices, diagnostics, and digital health companies—alongside venture capital firms, institutional investors, and strategic partners seeking new investment opportunities and syndication. Through its structured partnering format, LSX Europe facilitates meaningful conversations that translate into collaboration and successful fundraising.

Fierce Biotech Week is a multi-day gathering of biotech innovators, investors, and industry leaders focused on the future of drug development and life science innovation. With a lineup of high-impact sessions, networking opportunities, and partner events, it offers a dynamic platform for collaboration across R&D, clinical strategy, and investment in biotech.

The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most influential oncology conferences in the world. It highlights groundbreaking clinical research, emerging therapies, and advances in cancer care. A key event for sponsors, CROs, and life sciences professionals focused on oncology innovation and collaboration.

The American Diabetes Association’s Scientific Sessions is a leading forum for cutting-edge research, clinical advancements, and innovation in diabetes care. With sessions covering basic science, translational research, and clinical practice, this event brings together healthcare professionals, researchers, and industry leaders to drive progress in the prevention and treatment of diabetes.

The DIA Global Annual Meeting unites regulatory, industry, academic, and patient stakeholders to shape the future of healthcare product development. With a focus on global collaboration and innovation, the event covers regulatory science, clinical operations, medical affairs, and more—making it a must-attend for professionals across the life sciences.

The BIO International Convention is the world’s largest biotech partnering event, bringing together leaders from biotech, pharma, academia, and investment. With a focus on innovation, networking, and deal-making, BIO 2026 offers unparalleled opportunities to connect across the global life sciences ecosystem and drive forward the future of biotechnology.

Biotech Week Boston is a premier life sciences festival that brings together scientists, business leaders, and innovators from across the biopharma ecosystem. Featuring a series of co-located events—including conferences on cell and gene therapy, bioprocessing, and partnering—this weeklong gathering fosters connection, collaboration, and innovation at every stage of biotech development.

The premier annual meeting for professionals in infectious diseases, bringing together clinicians, researchers, public health experts, and industry leaders to share the latest advancements in prevention, diagnosis, treatment, and global health. The conference features cutting-edge scientific sessions, poster presentations, workshops, and networking opportunities designed to foster collaboration and innovation in the field of infectious diseases.

This leading regional event brings together clinical operations professionals from biotech, pharma, and medical device companies to explore outsourcing strategies and optimize trial delivery. Topics include vendor management, decentralized trials, patient recruitment, and regulatory updates—making it a key forum for streamlining clinical development in New England and beyond.

CNS Summit is a forward-thinking gathering of leaders from pharma, biotech, technology, and healthcare focused on driving innovation in clinical development and patient-centric solutions. Known for its collaborative environment and future-focused agenda, the summit explores advances in neuroscience, digital health, AI, and decentralized trials.